Metropolis Healthcare Limited (METROPOLIS) - Total Liabilities

Latest as of September 2025: Rs5.49 Billion INR ≈ $59.42 Million USD

Based on the latest financial reports, Metropolis Healthcare Limited (METROPOLIS) has total liabilities worth Rs5.49 Billion INR (≈ $59.42 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore METROPOLIS long-term investment intensity to see how much of total assets are deployed in long-term investments.

Metropolis Healthcare Limited - Total Liabilities Trend (2014–2025)

This chart illustrates how Metropolis Healthcare Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Metropolis Healthcare Limited assets under control.

Metropolis Healthcare Limited Competitors by Total Liabilities

The table below lists competitors of Metropolis Healthcare Limited ranked by their total liabilities.

Company Country Total Liabilities
Tungsten Mining NL
AU:TGN
Australia AU$9.77 Million
Viemed Healthcare Inc
NASDAQ:VMD
USA $66.86 Million
Top Gum Industries Ltd
TA:TPGM
Israel ILA85.07 Million
Jiangxi Everbright Measurement Cont
SHE:300906
China CN¥86.51 Million
MVB Financial Corp
NASDAQ:MVBF
USA $2.99 Billion
Yulie Sekurindo Tbk
JK:YULE
Indonesia Rp20.25 Billion
Honey Hope Honesty Enterprise Co Ltd
TWO:8043
Taiwan NT$1.83 Billion
Bredband2 i Skandinavien AB
ST:BRE2
Sweden Skr754.39 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Metropolis Healthcare Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Metropolis Healthcare Limited net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.16 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.20 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.38 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.28 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Metropolis Healthcare Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Metropolis Healthcare Limited (2014–2025)

The table below shows the annual total liabilities of Metropolis Healthcare Limited from 2014 to 2025.

Year Total Liabilities Change
2025-03-31 Rs5.33 Billion
≈ $57.61 Million
+16.87%
2024-03-31 Rs4.56 Billion
≈ $49.29 Million
-10.79%
2023-03-31 Rs5.11 Billion
≈ $55.25 Million
-20.44%
2022-03-31 Rs6.42 Billion
≈ $69.44 Million
+116.68%
2021-03-31 Rs2.96 Billion
≈ $32.05 Million
+30.51%
2020-03-31 Rs2.27 Billion
≈ $24.56 Million
+71.16%
2019-03-31 Rs1.33 Billion
≈ $14.35 Million
+31.09%
2018-03-31 Rs1.01 Billion
≈ $10.95 Million
-40.82%
2017-03-31 Rs1.71 Billion
≈ $18.49 Million
+67.59%
2016-03-31 Rs1.02 Billion
≈ $11.03 Million
+28.83%
2015-03-31 Rs791.99 Million
≈ $8.57 Million
+5.94%
2014-03-31 Rs747.56 Million
≈ $8.08 Million
--

About Metropolis Healthcare Limited

NSE:METROPOLIS India Diagnostics & Research
Market Cap
$334.90 Million
Rs30.97 Billion INR
Market Cap Rank
#14412 Global
#723 in India
Share Price
Rs597.45
Change (1 day)
+1.90%
52-Week Range
Rs421.75 - Rs2107.40
All Time High
Rs3431.71
About

Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India, Africa, South Asia, the Middle East, and internationally. The company offers routine and semi-specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; and clinic… Read more